STOCK TITAN

Medifast, Inc. - $MED STOCK NEWS

Welcome to our dedicated page for Medifast news (Ticker: $MED), a resource for investors and traders seeking the latest updates and insights on Medifast stock.

Medifast, Inc. (NYSE: MED), established in 1980, is a renowned nutrition and weight loss company based in Maryland. With the endorsement of over 20,000 doctors, Medifast is a trusted name in the industry, known for its clinically proven products developed by physicians. The company's mission is to empower individuals to lead healthier lives by providing effective weight loss and management solutions.

Medifast offers a diverse range of support programs tailored to meet the unique needs and goals of its customers. These programs are designed to help individuals achieve their health and wellness objectives through personalized guidance and scientifically backed products. The company’s vision is to create a world where people can easily take control of their own well-being, believing that healthier individuals lead happier lives.

One of the core aspects of Medifast's approach is its commitment to producing results and helping people succeed on their wellness journeys. The company generates revenue primarily through e-commerce transactions, where it sells various health and nutritional products aimed at promoting weight loss, weight management, and overall healthy living.

Recent achievements of Medifast include expanding its product line to cater to a broader audience and forming strategic partnerships to enhance its distribution network. The company’s current projects focus on leveraging technology to provide more personalized and accessible health solutions to its customers. Financially, Medifast has shown resilience and growth, reflecting its strong market position and the effectiveness of its business strategies.

Medifast's dedication to changing lives is evident in the numerous success stories of individuals who have transformed their health and well-being through its programs. By providing the right opportunities and support, Medifast continues to make a significant impact on the lives of many, fostering a sense of joy and achievement among its customers.

Rhea-AI Summary

Medifast (NYSE: MED), a health and wellness company, has been recognized as one of the 'Best Companies to Work For' in the food and drink industry for 2024-2025 by U.S. News & World Report. This marks the second consecutive year Medifast has received this distinction, highlighting its focus on creating a positive workplace culture. CEO Dan Chard credits the company's transformation to the dedication and resilience of its employees. The ranking, determined by a panel of experts, evaluates companies based on six factors important to employee well-being, including pay, benefits, work-life balance, and career opportunities. Medifast's OPTAVIA® program continues to drive its mission of promoting a healthy lifestyle.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.06%
Tags
none
-
Rhea-AI Summary

Medifast (NYSE: MED) has launched a national marketing campaign worth up to $30 million to promote its new GLP-1 Lifestyle Program, in collaboration with LifeMD. This program integrates clinician-prescribed medications, coach support, and a new GLP-1 Nutrition Support Kit. The campaign aims to drive customer acquisition and increase brand visibility. It includes new branding, visuals, and an enhanced digital presence. The GLP-1 Nutrition Support Kit, priced at $217.15/month via auto-ship, includes high-protein products designed to support weight management. Medifast's strategy focuses on marketing initiatives, coach network expansion, and strategic collaborations to drive growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags
none
-
Rhea-AI Summary

Medifast reported first quarter 2024 financial results with revenue of $174.7 million, net income of $8.3 million, and EPS of $0.76. The company highlighted a transformative approach to weight loss solutions, targeting a potential $50B market. However, revenue decreased by 49.9% primarily due to lower Coach productivity and active earning OPTAVIA Coaches. Gross profit decreased by 48.3%, while selling, general, and administrative expenses decreased by 38.1%. Income from operations decreased by 85.2% to $7.9 million. The company's balance sheet remained strong with $156.4 million in cash and no debt. The outlook for the second quarter 2024 includes revenue between $150 million to $170 million and diluted EPS between $0.05 to $0.40.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.47%
Tags
Rhea-AI Summary
Medifast (MED) will announce financial results for Q1 2024 on April 29, 2024. The conference call will feature Dan Chard, CEO, and Jim Maloney, CFO, discussing the results. Investors can join the call online or via telephone.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.87%
Tags
-
Rhea-AI Summary
Medifast (MED) reports fourth-quarter and full-year 2023 results, with revenue decline and strategic realignment efforts. The company's revenue for Q4 2023 was $191.0 million, showing a decrease from the previous year. Net income was $6.0 million, with EPS of $0.55. Full-year revenue for 2023 was $1.1 billion, with net income of $99.4 million. The company aims to broaden its customer acquisition activities and enter the medically-supported weight loss market through collaboration with LifeMD.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.47%
Tags
-
Rhea-AI Summary
Medifast (MED) will announce its Q4 and full year 2023 financial results on February 20, 2024. The company will host a conference call with the CEO and CFO to discuss the results. The call will be broadcast live and archived on the company's website. Telephone playback will also be available for a limited time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
Rhea-AI Summary
Medifast (MED) expands into the medically supported weight loss market through a collaboration with LifeMD (LFMD), making a $20 million capital commitment to drive growth. The company will discontinue its quarterly cash dividend to invest in customer acquisition and experience, aiming to reignite growth in the health and wellness landscape. The collaboration is expected to address the escalating obesity crisis and tap into the $100 billion weight loss market by 2030.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.42%
Tags
none
-
Rhea-AI Summary
Medifast reports Q3 2023 revenue of $235.9 million, a decrease of 39.6% compared to Q3 2022. Net income is $23.1 million with earnings per diluted share of $2.12. The company's balance sheet remains strong with $157.8 million in cash and no debt.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.5%
Tags
-
Rhea-AI Summary
Medifast to announce Q3 2023 financial results on November 6, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.22%
Tags
News
Rhea-AI Summary
Medifast announces the launch of its OPTAVIA ACTIVE line, designed to support muscle health and an active lifestyle. The line includes OPTAVIA ACTIVE Essential Amino Acid Blend and OPTAVIA ACTIVE Whey Protein. The products are backed by science, made with no artificial ingredients, and are Informed Sport certified. Medifast also partners with Aaptiv to provide personal training through a fitness app. Customers can save $10.00 on OPTAVIA ACTIVE products until October 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
none

FAQ

What is Medifast, Inc.?

Medifast, Inc. is a nutrition and weight loss company based in Maryland, known for its clinically proven products and endorsed by over 20,000 doctors.

How does Medifast generate its revenue?

Medifast generates revenue primarily through e-commerce transactions, selling a range of health and nutritional products aimed at weight loss and management.

What is the mission of Medifast?

Medifast's mission is to empower individuals to lead healthier lives by providing effective weight loss and management solutions.

What kind of support programs does Medifast offer?

Medifast offers several support programs tailored to meet the unique needs and goals of its customers, providing personalized guidance and scientifically backed products.

Where is Medifast, Inc. headquartered?

Medifast, Inc. is headquartered in Maryland, USA.

Who founded Medifast, Inc.?

Medifast, Inc. was developed by a physician and continues to be a clinically driven company.

What are some recent achievements of Medifast?

Recent achievements of Medifast include expanding its product line and forming strategic partnerships to enhance its distribution network.

What is Medifast's vision?

Medifast's vision is to create a world where it's easy for individuals to take control of their well-being, fostering healthier and happier lives.

What makes Medifast's approach effective?

Medifast's approach is effective due to its clinically proven products, personalized support programs, and commitment to producing tangible results for its customers.

How long has Medifast been in operation?

Medifast has been in operation since 1980, providing trusted and effective weight loss and nutrition solutions for over four decades.

Medifast, Inc.

NYSE:MED

MED Rankings

MED Stock Data

219.07M
9.64M
2.19%
108.33%
29.62%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
OWINGS MILLS